Vineet Laboratories Intrinsic Value
Vineet Laboratories (VINEETLAB) median intrinsic value is ₹72.88 from 3 valuation models (range ₹33–₹91), vs current price ₹36.44 — +100.0% upside (Trading Below Calculated Value), margin of safety 50.0%. Browse Vineet Laboratories annual reports for revenue, profit, balance sheet and cash flow data.
VINEETLAB Valuation Methods Summary — DCF, Graham Number & P/E
Vineet Laboratories intrinsic value across 3 models vs current price ₹36.44 — upside/downside and value range per method. For current market price and key ratios, visit Vineet Laboratories share price chart.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Book Value Method | asset | ₹33.33 | ₹30.00 - ₹36.66 | -8.5% | Book Value/Share: ₹16.67, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹72.88 | ₹65.59 - ₹80.17 | +100.0% | Revenue/Share: ₹62.22, P/S: 2.0x |
| Simple DCF (5Y) | dcf | ₹91.10 | ₹72.88 - ₹109.32 | +150.0% | CF Growth: 5.0%, Discount: 15% |
VINEETLAB Intrinsic Value vs Market Price — All Valuation Models
Vineet Laboratories fair value range ₹33–₹91 vs current market price ₹36.44 across 3 valuation models. Also explore VINEETLAB share price data to track price trends across different timeframes.
VINEETLAB Intrinsic Value Analysis — Undervalued or Overvalued?
Vineet Laboratories median intrinsic value ₹72.88, current price ₹36.44 — Trading Below Calculated Value by 100.0%, margin of safety 50.0%.
What is the intrinsic value of VINEETLAB?
Based on our comprehensive analysis using 3 different valuation methods, the estimated intrinsic value of Vineet Laboratories (VINEETLAB) is ₹72.88 (median value). With the current market price of ₹36.44, this represents a +100.0% variance from our estimated fair value.
The valuation range spans from ₹33.33 to ₹91.10, indicating ₹33.33 - ₹91.10.
Is VINEETLAB undervalued or overvalued?
Based on our multi-method analysis, Vineet Laboratories (VINEETLAB) appears to be trading below calculated value by approximately 100.0%.
VINEETLAB Financial Health — Key Ratios vs Industry Benchmarks
Vineet Laboratories financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 11.17 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | -66.7% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | -10.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.59x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
VINEETLAB Cash Flow Quality — Operating & Free Cash Flow
Vineet Laboratories operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹12 Cr | ₹11 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹-7 Cr | ₹-8 Cr | Negative Cash Flow | 3/10 |
| March 2023 | ₹-10 Cr | ₹-14 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹8 Cr | ₹6 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹28 Cr | ₹24 Cr | Positive Free Cash Flow | 8/10 |